Scale-up to semi-industrial cultivated fat production

Main Activities
Genuine Taste is an innovative biotechnology company focused on producing cultivated fat, a scalable and customizable ingredient for the growing alternative protein industry. We provide high-quality, structured fats that enhance the flavor, texture, aroma, and nutritional profile of plant-based and cultivated meat. Our technology offers a cost-effective alternative to conventional animal fats and synthetic flavor additives.
Challenge We Aim to Solve
Genuine Taste is developing a scalable, cost-effective solution for producing cultivated fat, a critical ingredient for enhancing the sensory and nutritional properties of alternative meats. The challenge we face is scaling our production
process from benchtop to demonstration scale, which is necessary to validate the unit economics and product quality for customers and investors. Achieving a price point of $10/kg is key to secure customer interest, but scaling to this level requires addressing new technical challenges such as optimizing yield, maintaining consistency, and ensuring product quality at a larger scale. Without this proof of scalability, it will be difficult to move forward with customer acquisition and pilot projects. The primary hurdle is scaling the production process to demonstration scale (10L bioreactor) while maintaining product quality and yield. The increased scale introduces complexities such as shear stress, contamination risks, and oxidation, which need to be addressed to ensure a consistent, high-quality product. This project will enable us to hire an experienced bioprocess engineer to refine our process and optimize production at this scale.
Anticipated Benefits to Genuine Taste
• Successful completion of this project will generate critical data proving the unit economics of our cultivated fat
production at demonstration scale (10L), a key milestone for commercialization.
• We will expand our in-house expertise in process engineering, strengthening our ability to scale production.
• We expect to file two new provisional patent applications, reinforcing our intellectual property portfolio.
• Our project will generate at least $50,000 in revenue from sample sales, with a portion coming from exports to
customers in the U.S. and the Netherlands.
• Meeting key technical milestones—such as three successful runs in a 10L bioreactor—will enable us to engage
with large food corporations, many of which require this validation before entering formal collaboration
agreements.